WAO Guideline for the Management of Hereditary Angioedema
Open Access
- 1 January 2012
- journal article
- Published by Elsevier BV in World Allergy Organization Journal
- Vol. 5 (12), 182-199
- https://doi.org/10.1097/wox.0b013e318279affa
Abstract
No abstract availableKeywords
This publication has 134 references indexed in Scilit:
- Hereditary angioedema (HAE) in children and adolescents—a consensus on therapeutic strategiesEuropean Journal of Pediatrics, 2012
- Safety and Efficacy of Physician-Supervised Self-Managed C1 Inhibitor Replacement TherapyInternational Archives of Allergy and Immunology, 2011
- Hereditary angioedema in womenAllergy, Asthma & Clinical Immunology, 2010
- Hereditary Angioedema Consensus 2010Allergy, Asthma & Clinical Immunology, 2010
- Prospective Study of Rapid Relief Provided by C1 Esterase Inhibitor in Emergency Treatment of Acute Laryngeal Attacks in Hereditary AngioedemaJournal of Clinical Immunology, 2010
- Grading quality of evidence and strength of recommendations in clinical practice guidelinesAllergy, 2009
- Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patientsAnnals of Allergy, Asthma & Immunology, 2008
- Possible disease-modifying factors: the mannan-binding lectin pathway and infections in hereditary angioedema of children and adultsArchivum Immunologiae et Therapiae Experimentalis, 2008
- An evaluation of tests used for the diagnosis and monitoring of C1 inhibitor deficiency: normal serum C4 does not exclude hereditary angio-oedemaClinical and Experimental Immunology, 2007
- C1-inhibitor concentrate home therapy for hereditary angioedema: a viable, effective treatment optionClinical and Experimental Immunology, 2006